Plain-English translation of NCT06671119 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a procedure called gastric mucosal ablation (GMA)—a minimally invasive treatment performed through an endoscope (a thin camera passed down your throat) that targets the stomach lining to help with weight regain. The procedure is designed for people who had sleeve gastrectomy surgery (a weight-loss operation that makes the stomach smaller) but have since regained significant weight. Researchers want to see if this treatment is safe, well-tolerated, and effective at helping people lose weight again.
Although sleeve gastrectomy surgery is very effective for weight loss initially, many people regain a substantial amount of weight over time. This trial exists to test whether this new endoscopic approach—which is less invasive than repeat surgery—can safely help people who experience weight regain without requiring major surgery again.
You likely qualify if…
You likely don't qualify if…
You would come to the clinic for a single endoscopic procedure where an experienced specialist will perform the gastric mucosal ablation treatment. The procedure involves passing a thin camera down your throat to carefully treat the stomach lining—no surgery needed. After the procedure, you'll participate in follow-up visits and complete pain assessments and questionnaires to help researchers understand how well the treatment works and how you tolerate it. You'll also need to commit to avoiding weight-loss medications and maintaining strict dietary restrictions throughout your participation.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States